1 / 56

Maryna Krawczuk-Rybak Department of Pediatric Oncology and Hematology

Blood morphology in non- haematological diseases of childhood : - interpretation of abnormal blood morphology - infections - gastrointestinal diseases - kidney disease s - connective tissue diseases - cardiovascular diseases - hormonal disorders - the effect of drugs. Maryna Krawczuk-Rybak

jsabb
Download Presentation

Maryna Krawczuk-Rybak Department of Pediatric Oncology and Hematology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Blood morphology in non-haematological diseases of childhood:- interpretation of abnormal blood morphology- infections- gastrointestinal diseases- kidney diseases- connective tissue diseases- cardiovascular diseases- hormonal disorders- the effect of drugs Maryna Krawczuk-Rybak Department of PediatricOncology and Hematology

  2. Hematopoietic system • Supply of oxygen to the tissues • Prevention of infections • Maintaining hemostasis The bone marrow produces daily: • 10¹² red blood cells • 10¹¹ whitebloodcells • 10¹¹ platelets

  3. The bone marrow is sensitive to diseases, which: • disrupt the anatomical integrity • inhibit the production of hematopoietic growth factors • stimulate the production of proinflammatory cytokines • Reduce the survival time of circulating bloodcells THE ANSWER TO THE QUESTION: • Is it a primary blood disease? • Or isit secondary, resulting from systemic disease? → Interview → Clinicalexamination (jaundice, telangiectasia, lymphadenopathy, hepatosplenomegaly, splenomegaly) → Analysis of bloodmorphology, bloodsmear, reticulocytosis

  4. Anemia Normal erythropoiesis is the result of 4 independent processes: • Proliferative abilityof the erythroid line of progenitor cells • Factors stimulating production of red blood cells • Sufficient nutritional requirements (iron, folic acid, vitamins) • Red blood cell survival (shortening due to premature destruction or bleeding)

  5. Anemia in the course of systemic diseases Hypoproliferativeanemias: • Vascularinflammation • Infections • Cancers • Diseases of kidney parenchyma • Hypopituitarism • Hypothyroidism • Disorders of absorption (celiacdisease)

  6. Aplasia / hypoplasia of the red-bloodcells system: • Hematopoieticmalignancies • Solid tumors, bloodmalignancies • Immunedisorders (collagenosis) • Infections (Parvovirus B19, EBV, Hepatitis A, B, C) • BMT Hemolyticanemias: • Infections (malaria, EBV, Bartonellahenselaeinfection, basesiosis, clostridium, mycoplasmosis) • Solid tumors • Wilson disease, microangiopathies (TTP, HUS, vasculitis, malignanthypertension, DIC)

  7. Anemia as a result of chronic diseases • Moderate or severe anemia • Low iron values and lowiron binding capacity • TIBC, transferrin - correct or low • Low transferrin saturation • Low iron storage in bone marrow • Normal or elevated level of ferritin •  low levels of EPO and reticulocytes • Inadequate EPO production due to:   - Increased intracellular iron accumulation -Stimulation of hepcidin production by: •         Proinflammatory cytokines → blocking the absorption of iron in the intestine •         Release of iron from macrophages

  8. Leukocytosis / leukopenia • Autoantibodies • Cytotoxic leukocytes (Felty syndrome: rheumatoid arthritis, neutropenia, splenomegaly) • Infections • Myelofibrosis • Hyperthyroidism • Splenic sequestration • Enteropathy with protein loss

  9. Blood platelets - thrombocytopenia 1. Disturbedproduction 2. Increasedplateletdestruction Both as a result of: • DIC • TTP (thromboticthrombocytopenic purpura) • Sepsis • Autoantibodies • Vasculitis • Inflammation • Splenicsequestration

  10. Excessive platelet production • Livercancer (hepatoblastoma, hepatocarcinoma) • Reactive: - Inflammation (leukocytosis, thrombocytopenia) • Anemia • aftersurgery / injury / burns • gastroesophagealreflux

  11. Pancytopenia Secondarybonemarrowaplasia in the course of: • Thymoma • Autoimmunediseases • Bonemarrownecrosis • Splenicsequestration • Hepatitis • Haemophagocyticsyndrome

  12. Leukaemoid reaction • Lymphoidormyeloid • Oftenafterinfection • Myeloidreaction (afterbacterialinfections, in proliferativediseases, TBC) → toxicgranularity in granulocytes, lowmyelocyte and myeloblastcount • Lymphoidreaction - in the pertussis - increase in the number of lymphocytes to 100 x 10⁹ / L, -Coxsackie viruses - lymphocytosis <50 x 10⁹ / L

  13. Infections Hematological response to infections depends on: • Type of invasion • State of health prior to infection Acutebacterialinfections → neutrophilia (exception: severeinfections / sepsis, prematureinfants - oftenparadoxicalneutropenia) • Growth of immatureneutrophils (BAND) • Subacute, chronicinfections (Salmonella, Brucella, TBC) → increase in monocytecount Viralinfections → transitionalneutrophilia (acutephaseresponse) → lymphocytecount and morphologyabnormalities Parasiticinfections → eosinophilia

  14. Anemia in the course of inflammation • Infections (bacterial, viral, fungal, parasitic) • Autoimmunediseases (LE, RA, sarcoidosis, vasculitis, inflammatoryboweldiseases) • Malignancies (lymphomas, solid tumors) • Chronicdiseases (cardiovascular, renal) ↓ • Disturbed iron homeostasis (stimulation of hepcidin by proinflammatory cytokines → reduced absorption of iron in the gastrointestinal tract) • Impaired erythropoiesis (as above+ sequestration of iron in macrophages → limiting of ironavailability for erythropoiesis) • Inhibitory effect of cytokines on progenitor cells of the red blood cell system • Accompanying vitamin B12deficiency and folic aciddeficiency

  15. Haemolytic anemia Haemolytic anemia with the presence of cold antibodies * Mycoplasma, * EBV Agglutination → increase in MCV, MCH, MCHC Paroxysmalnocturnalhaemoglobinuria (PNH): • Occursrarely • Acuteintravascularhemolysis • Afterviralinfections (mumps) • Parasitic and bacterialinfections (Clostridium welchii / perfringens, Bartonella, Plasmodium falciparum, Babesia)

  16. Selected infections: Tuberculosis: • anemia, • monocytosis, myeloidreactions, • thrombocytopenia, sometimes pancytopenia Epstein-Barr virus (infecting B lymphocytes): - leukocytosis, lymphocytosis, atypicalmononuclearcells - sometimesneutropenia (evensevere) - thrombocytopenia (in 1/3 of patients) - the presence of coldagglutinins → agglutination of red bloodcells -> hemolysis - spherocytosis, polychromasia

  17. HIV • Importance of the presence of the virus, malnutrition, presence of autoantibodies • Cytopenia: • Anemia, reticulocytopenia • Thrombocytopenia • Sometimesneutropenia (eg. afteranti-viraldrugs) Parvowirus B19 • Facial erythema, arthritis • Prolonged pancytopenia • Aplasia of the red-bloodcell system TORCH • Anemia, thrombocytopenia Kawasaki disease - neutrophilia - thrombocythemia

  18. Hemolytic uremic syndrome (HUS) • Microangiopathic hemolytic anemia + thrombocytopenia + acute renal failure • Anemia, reticulocytosis • thrombocytopenia • In the blood smear - the presence of schizocytes

  19. Thrombotic thrombocytopenic purpura - TTP • Usually during puberty • Symptoms like HUS + neurological disorders +/- fever, headache, muscle aches +/- hepatosplenomegaly, jaundice • ADAMTS-13 proteinase deficiency (decomposes large multimers of von Willebrand factor binding to surface antigens of thrombocytes causing aggregation); presence of anti-ADAMTS-13 antibodies

  20. Chronic renal diseases • EPO deficiency → abnormal erythropoiesis, • Increase in urea of 10 mmol / L → decrease in hemoglobin of 2 g / dL • Basically leucopoiesis and megakaryocytopoiesis are normal • Normochromatic normocytic anemia; + keratocytes, echinocytes • Hypersegmentation of neutrophils • Shortened red blood cell survival time (hemodialysis) • Efficient recombinant EPO treatment

  21. Chronic kidney disease (CKD) • At stage 1, anemia was found in 31% of children; atstage 4 and 5 in 93.3% • Anemia is more severe in infants and young children than in older children and adults. • Hypochromic, normocytic anemia due to iron and EPOdeficiency, in addition: - Reduced iron bindingcapacity - Deficiency in vitamins: folicacid, vit. B12 - Blood loss, includinguremicbleeding, caused by (for example) impairedfunction of the platelets - Inflammation - hyperparathyroidism - The use of immunosuppressivedrugs, angiotensinconvertingenzymeinhibitors (ACE-I)

  22. Chronic kidney disease (CKD) • Recommended diagnostic tests to explain the cause of anemia in chronic kidney disease (according to KDIGO 2012) • Patients with CKD and anemia should perform the following tests within the preliminary diagnosis: - Blood cell morphology and bloodsmear (automatic) - mean cell volume (MCV) and mean hemoglobin content in bloodcell (MCH) - total number of reticulocytes - serum ferritinconcentration • serum iron concentration and total iron bindingcapacity (TIBC) for calculating iron transferrinsaturation (TSAT); TSAT iscalculated as follows: serum iron concentration x 100 / TIBC • concentration of vitamin B12 in serum • concentration of folic acid in serum

  23. Chronic liver diseases Anemia: • Moderately macrocytotic(butmicrocyticis common in patients with hepatic failure and esophageal varices – due to bleeding from varices) • Hemolytic anemia - including other evidence of liver damage may suggest a suspicion of Wilson's disease Thrombocytopenia, leukopenia - due to hypersplenism, may be the first sign of chronic liver failure.

  24. Viral hepatitis • From minor anemia to aplastic anemia (immunization mechanism) • Reduction in reticulocytosis • Reduced survival time of erythrocytes • Macrocytosis • Leukopenia / lymphocytosis before jaundice • Thrombocytopenia

  25. Anemia in liver diseases Wilson's disease (disorder of copper metabolism) • liver, CNS, kidney, corneadamage → hemolytic anemia without morphological abnormalities or with the presence of Heinz's bodies (sudden release of copper from the liver) - sudden hemolytic episodes Reye's syndrome- appears a few days after the viral infection; associated with the use of aspirin -acute encephalopathy + degenerative changes in the liver - coagulation, thrombocytopenia

  26. Bowel diseases Crohn'sdisease, ulcerative colitis → • Inadequate absorption (iron, B12 vitamin, folates) • Bleeding • Sulfasalazine → folic acid deficiency, hemolysis • Treatment with folic acid → initially improvement in Hb value, but followed by microcytic anemia • Leucocytosis in the active phase of the disease • Eosinophilia, thrombocytosis – in inflammation of the intestines

  27. Celiac disease • Impaired absorption of iron, vitamin B6, vitamin B12, folic acid, riboflavin • Blood loss • Intestinal inflammation → cytotoxic effects of cytokines (INF-gamma, IL-6) → increase in hepcidin synthesis

  28. Hypochromic, microcytic anemia in 45-50% of children with subclinical celiac disease • Often the only symptom of celiac disease! • Low iron and ferritin concentration • an increase in UIBC • Treatment: gluten free diet + ironsupplementation + folic acid supplementation • Rarely: leukopenia (folic acid and copper deficiency) • Rare: thrombocytopenia (autoimmune)

  29. Iron deficiency and H. pylori infection • The only sign of infection, correction of iron deficiency after eradication of infection • hypochlorchydria → iron absorption disorders • Increased demand for iron - the use of alimentary iron by bacteria for its growth • Gastritis – place of iron sequestration • Bleeding from gastrointestinal tract • Possibility of bacterial production of a matriptase inhibitor - interference with the normal response of the intestinal mucosa - iron depletion

  30. Cardiac diseases Cyanotic heart diseases → tissue hypoxia → stimulation of EPO synthesis → polycythemia • Sometimes thrombocytopenia +/- platelet dysfunction • Sometimes symptoms of thrombosis (activation of the coagulation system) DiGeorge syndrome (chromosome 22 microdeletions) • Congenital heart defects • Facial anomalies • Immune disorders, lymphopenia, ↓ T lymphocytes

  31. Lung diseases • Hypoxia → polycythemia, increase in blood viscosity → decreased blood flow through tissues • Lung hemosiderosis - intravitreal microvascular bleeding, abnormal iron accumulation in the lungs (hemosiderin) → lung dysfunction, haemoptysis, dyspnea • Often the cyclical course of the disease • Iron deficiency anemia (microcytic) • ↓ iron level, ↑ iron binding capacity, sometimes eosinophilia • Loeffler's syndrome • Eosinophilic pneumonia with peripheral blood eosinophilia in the course of parasitic diseases

  32. Diseases of the endocrine glands Thyroid diseases Hypothyroidism: • Moderate normochromatic, macrocytic anemia, possible basophilia Hyperthyroidism : • The increase in MCH, Hb correct,possible lymphocytosis, neutropenia Adrenal insufficiency and hypopituitarism: • Moderate normochromatic anemia, lymphocytosis, eosinophilia, neutropenia Cushing's syndrome • ↑ in erythrocytes, hemoglobin, leucocytes, platelets (stimulation of bone marrow) • ↓ in circulating lymphocytes, monocytes, eosinophils (migration to extracellular space)

  33. Skin diseases Eczema • Moderate eosinophilia • Severe eczema / psoriasis: moderate anemia Wiskott-Aldrich syndrome: • Severe eczema, thrombocytopenia, small platelets • Immune disorders

  34. Choroby tkanki łącznej Juvenile chronic arthritis • Gastrointestinal bleeding (salicylates, steroids) → Iron deficiency → anemia • Secondary thrombocytopenia • Small leucocytosis • Splenomegaly → neutropenia Lupus erythematosus (LE) • The presence of autoantibodies against platelets (most commonly), erythrocytes, neutrophils → cytopenias → precursors growing in bone marrow • Anemia, leukopenia, lymphopenia, thrombocytopenia

  35. Polyarteritis nodosa • Microangiopathic hemolytic anemia • eosinophilia Wegener's granulomatosis • Cough, fever, hemoptysis, infiltration in the lungs, kidneys → • Normochromatic, normocytic anemia • Microangiopathic hemolytic anemia • Fragmentation of erythrocytes • Leukocytosis with neutrophilia and eosinophilia • Secondary thrombocytopenia

  36. Anorexia nervosa • severe malnutrition • moderate anemia, macrocytosis • neutropenia • thrombocytopenia

  37. Drugs • Myelosuppression • Bone marrow aplasia (chloramphenicol) • Cell survival time reduction • Immunological reactions

  38. Thrombocytopenia: • Creation of drug-binding antibody complexes • A drug (hapten) that binds to the surface of the plates • Stimulation of the production of antibodies reacting with antigens on the surface of the plates • Sodium valproate • Phenytoin • Carbamazepine • Rifampicin • Co-trimoxazole • Acetosolamide • Cimetidine • Aspirin • Heparin

  39. Classification of drugs due to association with aplastic anemia. Advances in Medical Sciences 4/2000, pp. 17-28 • Drugs that cause toxic bone marrow damage • Cytostatics used in cancer. • Alkylating agents (busulfan, melphalan, cyclophosphamide) • Antimetabolites (nucleotide analogs, folic acid antagonists) and antimitotic agents (vincristine, vinblastine, colchicine) • Antibiotics (daunorubicin, doxorubicin) 2. Drugs that are less likely to cause aplastic anemia. • Chloramphenicol • Non-steroidal anti-inflammatory drugs (phenylbutazone, indomethacin, ibuprofen, diclofenac, naproxen, piroxicam,fenoprofen, fenbufen, acetylsalicylic acid) • Anticonvulsants (hydontoin derivatives, carbamazepine, ethosuximide, fenacemide)Gold, arsenic, bismuth, mercurysalts • Sulfonamides • Antithyroid drugs (methimazole, metylotiuracyl, propylthiouracil) • Antidiabetic drugs (tolbutamide, carbutamide, chlorpropamide) • Inhibitors of carbonic anhydrase (acetazolamide, metazolamide, mesalazine) • D-penicillamine 3. Medications rarely causing aplastic anemia • Antibiotics (streptomycin, tetracyclines, ampicillin, methicillin, mebendazole, albendazole, flucytosine, dapsone, mefloquine) • Antihistamines (cimetidine, ranitidine, chlorpheniramine) • Calming agents (chlorpromazine, prochlorperazine, chlordiazepoxide, meprobamate, methyprone, remoksiprid) • Antiarrhythmics (amiodarone, tokainid) • Allopurinol (may increase the toxic effect of cytostatics on the bone marrow) • Other: ticlopidine, methyldopa, quinidine, lithium, guanidine, deferoxamine, carbimozole, amphetamine, furosemide, mepacrine.

  40. Drugs that cause immunohemolytic anemia

  41. Drugs and chemicals that can cause megaloblastosis

  42. Drugs that can cause sideroblastic anemia .

  43. Drugs that may induce selective aplasia of the red blood cell system

  44. Drugs that can cause granulocytopenia

  45. Drugs that can cause increased leukocytosis histamineCorticosteroidsnorepinephrinelithiumserotoninTetrakosaktydtetracycline

  46. Drugs that can cause eosinophilia Interleukin - 2GM - CSFchlorpromazinechlorpropamidephenytoinflucytosineKotrymoksazol PenicillinpentazocineprobucolGold saltsnitrofurantointetracyclinetetracycline .

  47. Drugs that can cause thrombocytopenia .

  48. Drugs that can cause immunotrombocytopenia

  49. Drugs that impair the function of the platelets (aggregation).

More Related